Outcome of Antibody‐Mediated Fetal Heart Disease With Standardized Anti‐Inflammatory Transplacental Treatment

BACKGROUND: Transplacental fetal treatment of immune‐mediated fetal heart disease, including third‐degree atrioventricular block (AVB III) and endocardial fibroelastosis, is controversial. METHODS AND RESULTS: To study the impact of routine transplacental fetal treatment, we reviewed 130 consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales: Mawad, Wadi, Hornberger, Lisa, Cuneo, Bettina, Raboisson, Marie‐Josée, Moon‐Grady, Anita J., Lougheed, Jane, Diab, Karim, Parkman, Julia, Silverman, Earl, Jaeggi, Edgar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238501/
https://www.ncbi.nlm.nih.gov/pubmed/35001672
http://dx.doi.org/10.1161/JAHA.121.023000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238501/
https://www.ncbi.nlm.nih.gov/pubmed/35001672
http://dx.doi.org/10.1161/JAHA.121.023000

Ejemplares similares